Relationship between Acute-Phase Symptoms and Immunoglobulin G Seropositivity up to Eight Months after COVID-19COVID-19 이후 최대 8개월까지 급성기 증상과 면역글로불린 G 혈청양성 간의 관계Article Published on 2022-05-262022-09-11 Journal: Medicina [Category] MERS, 진단, 치료제, [키워드] acute phase adjusted analyzed Anosmia antibody Antibody Response Antibody responses chance classification clinical manifestation COVID-19 creating cross-sectional cross-sectional study dependence determinants Dyspnea effective HCW HCWs healthcare worker highest IgG Immunoglobulin Immunoglobulin G knowledge Logistic regression material Month multiple logistic regression Occurrence Odds ratio post-symptom onset proportion relationship responses S1 and S2 serology testing seronegative Seropositivity significantly increased Spike protein Surveillance Symptom symptom onset tested the spike protein was increased [DOI] 10.3390/medicina58060708 PMC 바로가기 [Article Type] Article
Adequacy of Hemodialysis Serves as an Independent Predictor of Humoral Response to ChAdOx1 Prime-Boost Vaccination in Hemodialysis Patients혈액 투석의 적절성은 혈액 투석 환자의 ChAdOx1 프라임 부스트 백신 접종에 대한 체액 반응의 독립적인 예측 인자로 작용합니다Article Published on 2022-05-262022-09-12 Journal: Viruses [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 1.26 acute respiratory syndrome Adequacy analyzed ANOVA antibody applied ChAdOx1 coronavirus correlation COVID-19 COVID-19 vaccine dialysis domain dose enrolled enzyme-linked immunosorbent evaluate geometric mean titer healthy control healthy subject Hemodialysis hemodialysis adequacy Multiple linear regression neutralization neutralization titer Neutralizing Neutralizing antibodies neutralizing antibody Oxford-AstraZeneca parameter Patient predict predictor Prospective Study quantification regression analysis response Seroconversion seronegative seropositive subject the spike protein vaccination Vaccine [DOI] 10.3390/v14061149 PMC 바로가기 [Article Type] Article
Risk of COVID-19 re-infection and its predictors (CORES): protocol for a community-based longitudinal cohort study in Vellore, IndiaCOVID-19 재감염 및 그 예측인자(CORES)의 위험: 인도 벨로르에서 지역사회 기반 종단 코호트 연구를 위한 프로토콜Article Published on 2022-05-242022-09-11 Journal: BMJ Open [Category] COVID19(2023년), SARS, 치료기술, [키워드] analysed antibody Antibody responses approved attack rate B cell memory baseline blood sample Blood samples collected college Community community setting COVID-19 defined detect elicited Ethics evaluated Evidence evidence of expected Factor General population group Health policy healthy immune response immune responses immunology incidence India Infection institutional review board IRB Kinetics Longevity longitudinal cohort study natural infection positive Post-infection predictor presence of antibody Primary infection protocol public health Re-infection recruit registration number registry responses reverse transcription-PCR risk risk factor Risk factors RT-PCR Saliva saliva samples SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 infections SARS-CoV-2 spike protein seronegative seropositive Seropositivity Seroprevalence seroprevalence survey Spike protein T cell T cell memory tested understanding vaccination Vaccination Status Weekly [DOI] 10.1136/bmjopen-2021-059869 PMC 바로가기 [Article Type] Article
Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against OmicronSARS-CoV-2 회복 아동의 장기 면역 및 오미크론에 대한 중화 능력Article Published on 2022-05-172022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] activity Against antibody Antibody Response Antigen Asymptomatic Capacity CD4 T cell CD8 T cell CD8 T cells cellular immune responses children Cohort COVID-19 cross-neutralization D614G declined effectively controlled fold humoral Humoral and cellular immune responses immune immune memory immune responses Immunity IMPROVE induce Infection lack memory T cell memory T cells Mild neutralization neutralize Neutralizing activity Neutralizing antibodies neutralizing antibody omicron pre-existing immunity pre-immune recall remained response robust SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-specific T cells seronegative T cell T cells vaccination Vaccine vaccine response variant variants variants of concern [DOI] 10.3389/fimmu.2022.882456 PMC 바로가기 [Article Type] Article
Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity장기 allo-HSCT 생존자에서 백신 접종 후 SARS-CoV-2 T-세포 반응의 결핍은 체액성 면역 감소로 해석됩니다Article Published on 2022-05-102022-09-11 Journal: Blood advances [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 allo-HSCT Allogeneic allogeneic hematopoietic stem cell transplantation Amino acid analyzed anti-RBD BNT162b2 Control coronavirus COVID-19 COVID-19 vaccines death deficiency detectable determine disease Ex vivo Fisher Fisher's exact test healthy control hematological Hematopoietic stem cell HSCT Humoral immunity humoral responses IgG immunogenicity Immunoglobulin Immunoglobulin G interferon interferon-γ lack median mRNA mRNA-1273 Odds ratio of BNT162b2 overlap Patient peptide peptides rate of seroconversion RBD reactivity Receptor binding domain recipient recipients reflected respiratory risk S1 IgG SARS-CoV-2 second vaccination Seroconversion seronegative serum severe acute respiratory syndrome Coronavirus severe disease significantly lower stem cell Stem cell transplantation stimulated substandard survivor T-cell T-cell immunity T-cell Response T-cell responses translate transplantation vaccination Vaccinations vaccine dose Whole blood [DOI] 10.1182/bloodadvances.2021006937 PMC 바로가기 [Article Type] Article
Immunogenic epitope panel for accurate detection of non-cross-reactive T cell response to SARS-CoV-2SARS-CoV-2에 대한 비교차 반응성 T 세포 반응의 정확한 검출을 위한 면역원성 에피토프 패널Article Published on 2022-05-092022-09-11 Journal: JCI Insight [Category] COVID19(2023년), SARS, 치료기술, [키워드] absence Accuracy Antigen antigens association Asymptomatic clinical clinical trial clinical trials Cohort collected Combination Complete contributing to convalescent COVID-19 COVID-19 pandemic cross-reactive described diagnostic Diagnostic accuracy diagnostic specificity donors effective epitope Epitopes exclusion full-length healthy HLA HLA allele Immune cell immune cells immunodominant immunogenic immunogenicity in vitro independent individual individuals offered peptides PROTECT reactivity robust SARS-CoV-2 SARS-CoV-2 immunity sensitivity seronegative specificity T cell T cell response T cells [DOI] 10.1172/jci.insight.157699 PMC 바로가기 [Article Type] Article
Long-Term Comparison of 7 SARS-CoV-2 Antibody Assays in the North Zealand Covid-19 CohortNorth Zealand Covid-19 코호트에서 7개의 SARS-CoV-2 항체 분석의 장기 비교Article Published on 2022-05-042022-09-11 Journal: The journal of applied laboratory medicine [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료법, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibody assay Antibody assays approved authorization automated binding domain clinical laboratory Cohort comparison study Consensus coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 detect diagnostic diagnostic sensitivity discrepancy ELISA assay ELISA assays Emergency Emergency use authorization immunoassay immunoassays implementation investigated Laboratory longitudinal study North pandemic PCR PCR-confirmed PCR-positive patient plateau platform raise reached remained respiratory Roche SARS-CoV-2 SARS-CoV-2 antibodies SARS-COV-2 infection SARS-CoV-2-positive individual sensitivities sensitivity Sensitivity and specificity Serological testing seronegative Seropositivity Siemens subpopulation Thermo Fisher Scientific [DOI] 10.1093/jalm/jfab173 PMC 바로가기 [Article Type] Article
Antibody response with SARS-CoV-2 inactivated vaccine (CoronaVac) in Turkish geriatric population터키 노인 인구에서 SARS-CoV-2 비활성화 백신(CoronaVac)에 대한 항체 반응Article Published on 2022-05-012022-09-11 Journal: Age and Ageing [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] affecting Anti-spike anti-Spike IgG Antibody Response association best Charlson Comorbidity Index clinical Comorbidity Comprehensive CoronaVac COVID-19 vaccine defined Factor frailty geriatric assessment group IgG antibodies IgG antibody Inactivated vaccine individual Infection influence knowledge neutralising neutralising antibody Older older people Patient patients performed Prevalence response duration SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike-specific SARS-CoV-2 spike-specific IgG antibodies scale second dose seronegative seropositive Seropositivity significantly higher Sinovac specific IgG antibodies the antibody response the vaccine three group three groups U/mL vaccination [DOI] 10.1093/ageing/afac088 PMC 바로가기 [Article Type] Article
The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patients면역 억제 환자의 항 SARS-CoV-2 항체 수준에 대한 3차 접종 BNT162b2 백신의 효과Observational Study Published on 2022-05-012022-09-12 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] 95% CI acute respiratory syndrome Administered anti-SARS-CoV-2 antibody antibody Antibody Response baseline BNT162b2 BNT162b2 vaccine booster booster dose Booster vaccine clinical outcomes Cohort cohorts coronavirus coronavirus disease COVID-19 disease Diseases dose entire cohort evaluate expressed Fold change haematologic highest hospital IgG antibody immunogenic Immunosuppressed immunosuppressed patient Immunosuppression increase in individuals interquartile range IQR Level malignancies Observational cohort study of BNT162b2 Patient patients Pfizer-BioNTech mRNA vaccine recipients rheumatology SARS-CoV-2 seroconversion rate seronegative seropositive significantly spike receptor-binding domain the median Transplant vaccination Vaccine were measured [DOI] 10.1016/j.cmi.2022.02.002 PMC 바로가기 [Article Type] Observational Study
Elevated CD21 low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency증가된 CD21 낮은 B 세포 빈도는 공통 가변성 면역결핍증 환자에서 SARS-CoV-2에 대한 화이자-바이오엔텍 BNT162b2 mRNA 백신에 대한 면역 저하의 지표입니다Clinical Trial Published on 2022-05-012022-09-12 Journal: Journal of Clinical Immunology [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] affected Against analyzed antibody B-cell baseline BNT162b2 mRNA BNT162b2 mRNA vaccination BNT162b2 mRNA vaccine CD21 CD21low B-cells CD4 cell count central memory clinical trial cohort of patient common correlated COVID-19 COVID-19 vaccination CVID demonstrated dose Frequency healthy control Humoral immunity IFN-γ IgG immune response immunocompromised individuals immunodeficiency Limited median titer memory B-cell Open-label Patient patients patients with CVID Pfizer-BioNTech Pfizer-BioNTech BNT162b2 mRNA vaccine Poor positive proportion reached reduced response SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 spike-specific second dose selected seroconverted seronegative significantly single-center T cell response T-cell the vaccine threshold vaccine responses variable were assessed [DOI] 10.1007/s10875-022-01244-2 PMC 바로가기 [Article Type] Clinical Trial